EAS National Society Newsletter: EAS Congress 2021

Obavještavamo članstvo da je produžen rok za slanje sažetaka za 21. virtualni EAS kongres 2021 do 26. januara 2021. godine

Dear Working Group for Atherosclerosis of Association of cardiologists in Bosnia and Herzegovina member

We write to share with you news from EAS, both for you as a President and for your National Society members. In this letter you will find information about EAS Congress 2021, National Society President meeting and New Commentary: SAMSON, SAMS and nocebo effects.

We would like to introduce you to our new President Kausik Ray

Kausik Ray is Professor of Public Health at the School of Public Health, the Director of the Imperial Centre for Cardiovascular Disease Prevention and the Deputy Director of the Imperial Clinical Trial Unit, Imperial College London and a Consultant Cardiologist.

Professor Ray received his medical education (MBChB) at the University of Birmingham, his MD at the University of Sheffield, a postdoctoral fellowship at Harvard Medical School and an MPhil in epidemiology from the University of Cambridge.

Read more about EAS President

We welcome National Societies members to submit an abstract to EAS Virtual Congress 2021!

We encourage clinicians and basic researchers studying atherosclerosis and related vascular disease to take an active part in EAS 2021 by submitting an abstract of your own research.

The EAS Congress continues to be a leading conference to showcase research for young and old researchers from all around the world. Last year more than 1000 abstracts & talks were presented at our event.

There is still time to showcase your work to a global audience at EAS 2021!

Abstracts presented as part of the Congress programme will be published in the Society’s internationally recognised Atherosclerosis journal.

Extended Abstract submission deadline: Tuesday January 26, 2021!

Read more about submitting an abstract

EAS National Society President Meeting at EAS Virtual Congress 2021

EAS coordinate an annual meeting of the Presidents of national societies, to facilitate collaborative approaches to the scientific, social and political challenges that many organisations face.

This year National Society President Meeting will be a virtual meeting, Saturday May 29 at 18.00 CET. An invitation letter will be sent out to National Society Presidents.

Anitschkow winner 2021 – Professor Sir Rory Collins

The European Atherosclerosis Society is pleased to announce that Professor Sir Rory Collins has been awarded the 2021 Anitschkow Award. The Anitschkow Award is given for outstanding research in the field of atherosclerosis and linked metabolic disturbances.

The 2021 award recognizes the transformative national and international contributions that Professor Collins has made in investigating the causes, prevention, and treatment of cardiovascular disease. Notably, studies that he led have established statins as the standard of care for managing hypercholesterolemia and saving millions of lives globally.

The award also recognizes Professor Collins for his visionary leadership of the UK Biobank, a major contributor to the advancement of modern medicine which has enabled scientific discoveries that improve human health.

Read more about Anitschkow winner Professor Collins >>

New Commentary: SAMSON, SAMS and nocebo effects

Statins are foundational for the management of hypercholesterolaemia to prevent atherosclerotic cardiovascular disease (ASCVD), as reaffirmed in the 2019 European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) lipid guidelines.

A key deterrent to the efficacious use of statin therapy, however, is statin intolerance, which contributes to treatment non-adherence and/or discontinuation, and adverse cardiovascular outcomes. Management of statin intolerance is hampered by the heterogeneity of symptoms reported by patients, and the lack of internationally agreed clinical criteria, validated biomarkers or diagnostic tools.

To the commentary: SAMSON, SAMS & nocebo effects >>